NEULAND LABORATORIES LTD.
|
Market Cap.(`)
|
21382.29 Cr.
|
P/BV
|
16.68
|
Book Value (`)
|
999.07
|
|
52 Week High/Low ( ` )
|
16561/4926
|
FV/ML
|
10/1
|
P/E(X)
|
71.26
|
|
Book Closure
|
15/07/2024
|
EPS (`)
|
233.89
|
Div Yield (%)
|
0.08
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 1515.66 | 1160.90 | 923.33 | 918.18 | 734.45 |
| Other Operating Revenues | 42.92 | 30.30 | 27.74 | 18.74 | 28.26 |
| Total Operating Revenues | 1558.58 | 1191.20 | 951.08 | 936.91 | 762.71 |
| | | | | | |
| Other Income | 12.54 | 9.75 | 2.08 | 16.10 | 3.89 |
| Total Revenue | 1571.12 | 1200.95 | 953.15 | 953.01 | 766.60 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 632.43 | 487.74 | 437.55 | 439.66 | 391.36 |
| Operating And Direct Expenses | 156.51 | 135.56 | 131.36 | 120.29 | 97.60 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -55.14 | -9.51 | -15.41 | -1.24 | -11.16 |
| Employee Benefit Expenses | 257.06 | 201.79 | 182.47 | 149.74 | 123.56 |
| Finance Costs | 14.00 | 13.07 | 13.50 | 17.90 | 21.57 |
| Depreciation And Amortisation Expenses | 59.70 | 52.78 | 49.04 | 39.68 | 31.28 |
| Other Expenses | 105.13 | 103.78 | 72.48 | 81.66 | 59.47 |
| Total Expenses | 1169.69 | 985.20 | 870.99 | 847.67 | 713.67 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 401.44 | 215.75 | 82.16 | 105.33 | 52.92 |
| | | | | | |
| Profit/Loss Before Tax | 401.44 | 215.75 | 82.16 | 105.33 | 52.92 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 99.67 | 50.44 | 20.43 | 12.56 | 0.10 |
| Deferred Tax | 1.69 | 1.79 | -2.09 | 12.15 | 36.62 |
| Total Tax Expenses | 101.36 | 52.23 | 18.34 | 24.70 | 36.71 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 300.08 | 163.52 | 63.82 | 80.63 | 16.21 |
| | | | | | |
| Profit/Loss From Continuing Operations | 300.08 | 163.52 | 63.82 | 80.63 | 16.21 |
| | | | | | |
| Profit/Loss For The Period | 300.08 | 163.52 | 63.82 | 80.63 | 16.21 |
| Consolidated Profit/Loss After MI And Associates | 300.08 | 163.52 | 63.82 | 80.63 | 16.21 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 233.89 | 127.45 | 49.74 | 62.85 | 12.63 |
| Diluted EPS (Rs.) | 233.89 | 127.45 | 49.74 | 62.85 | 12.63 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 12.83 | 6.41 | 3.85 | 2.57 | 4.95 |